home / stock / opnt / opnt news


OPNT News and Press, Opiant Pharmaceuticals Inc. From 08/07/21

Stock Information

Company Name: Opiant Pharmaceuticals Inc.
Stock Symbol: OPNT
Market: NASDAQ

Menu

OPNT OPNT Quote OPNT Short OPNT News OPNT Articles OPNT Message Board
Get OPNT Alerts

News, Short Squeeze, Breakout and More Instantly...

OPNT - Opiant Pharmaceuticals, Inc. (OPNT) CEO Roger Crystal on Q2 2021 Results - Earnings Call Transcript

Opiant Pharmaceuticals, Inc. (OPNT) Q2 2021 Earnings Conference Call August 05, 2021, 16:30 ET Company Participants Ben Atkins - VP, Communications & IR Roger Crystal - President, CEO & Director David O'Toole - CFO Conference Call Participants Carl Byrnes - Northland Capital Markets D...

OPNT - Opiant Pharmaceuticals Announces Second Quarter 2021 Financial Results and Provides Corporate Update

SANTA MONICA, Calif., Aug. 05, 2021 (GLOBE NEWSWIRE) -- Opiant Pharmaceuticals, Inc. (“Opiant”) (NASDAQ: OPNT), a specialty pharmaceutical company developing medicines to treat addictions and drug overdose, today reported financial results for the three and six months end...

OPNT - Opiant Pharmaceuticals to Report Second Quarter 2021 Financial Results and Host Conference Call and Webcast on August 5, 2021

SANTA MONICA, Calif., July 22, 2021 (GLOBE NEWSWIRE) -- Opiant Pharmaceuticals, Inc. (“Opiant”) (NASDAQ: OPNT), a specialty pharmaceutical company developing medicines for addictions and drug overdose, today announced it will report its financial results for the seco...

OPNT - Opiant Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

SANTA MONICA, Calif., July 20, 2021 (GLOBE NEWSWIRE) -- Opiant Pharmaceuticals, Inc. (“Opiant”) (NASDAQ: OPNT), a specialty pharmaceutical company developing medicines to treat addictions and drug overdose, today announced, as required by Nasdaq Stock Market rules, the gr...

OPNT - Opiant Pharmaceuticals Announces Appointment of Matthew Ruth as Chief Commercial Officer

Mr. Ruth led the highly successful launch and commercialization of the first FDA-approved nasal naloxone spray to treat opioid overdose He joins Opiant at a time when the Company is developing and moving towards potential commercialization of OPNT003, nasal nalmefene, a novel...

OPNT - IP, BTU, ONCS among pre market gainers

Newegg Commerce NEGG +148%.Mannatech (MTEX) +50%.Data Storage (DTST) +33%.iPower  (IPW) +32%.Peabody Energy BTU +25%.Dare Bioscience (DARE) +24%.Vivos Therapeutics (VVOS) +24%.Exela Technologies (XELA) +23%.OncoSec Medical  (ONCS) +22%.Opiant Pharmaceuticals (OPNT) +21%.SM...

OPNT - BTU, ONCS, DARE among mid-day movers

Newegg Commerce (NEGG) +115%.Dare Bioscience (DARE) +35%.Opiant Pharmaceuticals (OPNT) +32%.Data Storage (DTST) +32%.OncoSec Medical (ONCS) +30%.Peabody Energy (BTU) +27%.iPower (IPW) +21%.SMART Global Holdings (SGH) +20%.Virpax Pharmaceuticals (VRPX) +18%.X Financial...

OPNT - OncoSec Medical and Dare Bioscience among healthcare gainers; Soligenix among losers

Gainers: Virpax Pharmaceuticals (VRPX) +46%. Opiant Pharmaceuticals (OPNT) +31%. OncoSec Medical (ONCS) +24%. Dare Bioscience (DARE) +18%. Biohaven Pharmaceutical Holding Company (BHVN) +12%.Losers: IDEAYA Biosciences (IDYA) -24%. Cleveland BioLabs (CBLI) -20%. Soligenix (SNGX) -16%...

OPNT - CLOV, CRNT among premarket gainers

Data Storage (DTST) +68%.Dare Bioscience (DARE) +43% on grant from Gates Foundation.Opiant Pharmaceuticals (OPNT) +38% on OPNT003 opioid overdose study results.OncoSec Medical (ONCS) +28% after teaming up with Merck for late-stage TAVO/Keytruda trial.Blonder Tongue Laboratories...

OPNT - Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Good morning, trader! Let’s get right into it today with a quick dive into the biggest pre-market stock movers for Wednesday. Source: ventdusud / Shutterstock.com Also, investors wanting to catch up on yester...

Previous 10 Next 10